These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 37029369)

  • 1. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemsex and diagnoses of syphilis, gonorrhoea and chlamydia among men who have sex with men in the UK: a multivariable prediction model using causal inference methodology.
    MacGregor L; Kohli M; Looker KJ; Hickson F; Weatherburn P; Schmidt AJ; Turner KM
    Sex Transm Infect; 2021 Jun; 97(4):282-289. PubMed ID: 33452129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.
    van Wees DA; Diexer S; Rozhnova G; Matser A; den Daas C; Heijne J; Kretzschmar M
    Sex Transm Infect; 2022 Sep; 98(6):395-400. PubMed ID: 34716228
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence of changing sexual behaviours and clinical attendance patterns, alongside increasing diagnoses of STIs in MSM and TPSM.
    MacGregor L; Speare N; Nicholls J; Harryman L; Horwood J; Kesten JM; Lorenc A; Horner P; Edelman NL; Muir P; North P; Gompels M; Turner KME
    Sex Transm Infect; 2021 Nov; 97(7):507-513. PubMed ID: 34413201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study.
    Jongen VW; Zimmermann HML; Goedhart M; Bogaards JA; Davidovich U; Coyer L; de Vries HJC; Prins M; Hoornenborg E; Schim van der Loeff MF;
    Sex Transm Infect; 2023 May; 99(3):149-155. PubMed ID: 35584898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexually Transmitted Infection Screening Among Gay, Bisexual, and Other Men Who Have Sex With Men Prescribed Pre-exposure Prophylaxis in Baltimore City, Maryland.
    Schumacher C; Wu L; Chandran A; Fields E; Price A; Greenbaum A; Jennings JM;
    Clin Infect Dis; 2020 Dec; 71(10):2637-2644. PubMed ID: 31761944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP Trial.
    Cornelisse VJ; Fairley CK; Stoove M; Asselin J; Chow EPF; Price B; Roth NJ; Willcox J; Tee BK; Penn M; Chang CC; Armishaw J; Forgan-Smith G; Wright EJ;
    Clin Infect Dis; 2018 Nov; 67(12):1847-1852. PubMed ID: 29741665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
    Hovaguimian F; Kouyos RD; Kusejko K; Schmidt AJ; Tarr PE; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Darling KEA; Depmeier C; Läuchli S; Reinacher M; Rasi M; Nicca D; Bruggmann P; Haerry D; Bize R; Low N; Vock F; El Amari EB; Böni J; Bosshard PP; Fehr JS; Hampel B;
    HIV Med; 2024 Jan; 25(1):117-128. PubMed ID: 37771207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
    Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C;
    BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
    Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA;
    Lancet Infect Dis; 2022 Aug; 22(8):1231-1241. PubMed ID: 35643090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E;
    PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022.
    von Schreeb S; Pedersen SK; Christensen H; Jørgsensen KM; Harritshøj LH; Hertz FB; Ahlström MG; Lebech AM; Lunding S; Nielsen LN; Gerstoft J; Kronborg G; Engsig FN
    Euro Surveill; 2024 Mar; 29(13):. PubMed ID: 38551099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort.
    Nozza S; Raccagni AR; Lolatto R; Ceccarelli D; Galli L; Alberton F; Bruzzesi E; Canetti D; Strano M; Ripa M; Bertoni C; Castagna A
    BMJ Open; 2022 Dec; 12(12):e067261. PubMed ID: 36600429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.
    Kiefer EM; Ross KS; Santos AC; Barney MR; McCormick TJ; Chow DC; Shikuma CM
    Hawaii J Health Soc Welf; 2021 Jul; 80(7):148-154. PubMed ID: 34278321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the burden of self-reported bacterial sexually transmitted infections among men having sex with men across 68 countries on four continents.
    Marcus U; Veras M; Casabona J; Caceres CF; Lachowsky N; Schink SB; Schmidt AJ
    BMC Public Health; 2023 May; 23(1):1008. PubMed ID: 37254096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
    Streeck H; Jansen K; Crowell TA; Esber A; Jessen HK; Cordes C; Scholten S; Schneeweiss S; Brockmeyer N; Spinner CD; Bickel M; Esser S; Hartikainen J; Stoehr A; Lehmann C; Marcus U; Vehreschild JJ; Knorr A; Brillen AL; Tiemann C; Robb ML; Michael NL
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.